Cargando…

An Analysis of Inpatient Tobacco Use Treatment Transition to Telehealth

INTRODUCTION: During the COVID-19 pandemic, many tobacco users increased their tobacco use, and calls to quitlines decreased. Among inpatients, the pandemic also necessitated a rapid transition of intensive tobacco use counseling to telehealth counseling. No data exist comparing the outcomes of tele...

Descripción completa

Detalles Bibliográficos
Autores principales: Shoenbill, Kimberly A, Newcomer, Eiman, Valcourt-Hall, Celeslie, Baca-Atlas, Michael H, Smith, Caleb A, Goldstein, Adam O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962722/
https://www.ncbi.nlm.nih.gov/pubmed/34929731
http://dx.doi.org/10.1093/ntr/ntab233
_version_ 1784677857245528064
author Shoenbill, Kimberly A
Newcomer, Eiman
Valcourt-Hall, Celeslie
Baca-Atlas, Michael H
Smith, Caleb A
Goldstein, Adam O
author_facet Shoenbill, Kimberly A
Newcomer, Eiman
Valcourt-Hall, Celeslie
Baca-Atlas, Michael H
Smith, Caleb A
Goldstein, Adam O
author_sort Shoenbill, Kimberly A
collection PubMed
description INTRODUCTION: During the COVID-19 pandemic, many tobacco users increased their tobacco use, and calls to quitlines decreased. Among inpatients, the pandemic also necessitated a rapid transition of intensive tobacco use counseling to telehealth counseling. No data exist comparing the outcomes of telehealth inpatient counseling with in-person (pre-telehealth) counseling. AIMS AND METHODS: We examined inpatient data from a large tobacco treatment program (TTP) during two comparable time periods 04/01/2019–09/30/2019 (pre-telehealth) and 04/01/2020–09/30/2020 (telehealth). The pre-telehealth and telehealth populations were compared using Pearson’s chi-square test for homogeneity on each populations’ patient, visit, and medication acceptance characteristics. Reach to “current tobacco users” was analyzed using TTP flowsheet and electronic health record (EHR) data in relation to aggregate EHR data in the data warehouse. RESULTS: Mean monthly tobacco treatment inpatient counseling and outreach visits increased 38.9% in the telehealth period (M = 376, SD = 36.7) compared with the pre-telehealth period (M = 271, SD = 50.0) (t(10) = 3.8, p = .004). Reach significantly increased from 32.8% to 65.9% among all “current tobacco users” admitted, including 31.8% to 66.6% in races at higher risk for COVID-19 severe disease. Pearson’s chi-square tests for homogeneity showed significant differences in the pre-telehealth and telehealth population distributions for age, visit type, ethnicity, and medication acceptance. CONCLUSIONS: This study offers the first understanding of characteristics of patients, visits, and medication acceptances in pre-telehealth and telehealth tobacco use treatment for inpatient populations. Larger reach and counseling were identified in the telehealth population. This study’s findings on inpatient tobacco use treatment can inform future reach and engagement of large numbers of patients who use tobacco products. IMPLICATIONS: This study provides the first analysis of inpatient tobacco use treatment transition to telehealth delivery of care during the COVID-19 pandemic. The transition resulted in increases in reach and cessation counseling. These findings can inform efforts to improve reach, engagement, and research on telehealth delivery of inpatient tobacco use treatment.
format Online
Article
Text
id pubmed-8962722
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-89627222022-08-17 An Analysis of Inpatient Tobacco Use Treatment Transition to Telehealth Shoenbill, Kimberly A Newcomer, Eiman Valcourt-Hall, Celeslie Baca-Atlas, Michael H Smith, Caleb A Goldstein, Adam O Nicotine Tob Res Brief Reports INTRODUCTION: During the COVID-19 pandemic, many tobacco users increased their tobacco use, and calls to quitlines decreased. Among inpatients, the pandemic also necessitated a rapid transition of intensive tobacco use counseling to telehealth counseling. No data exist comparing the outcomes of telehealth inpatient counseling with in-person (pre-telehealth) counseling. AIMS AND METHODS: We examined inpatient data from a large tobacco treatment program (TTP) during two comparable time periods 04/01/2019–09/30/2019 (pre-telehealth) and 04/01/2020–09/30/2020 (telehealth). The pre-telehealth and telehealth populations were compared using Pearson’s chi-square test for homogeneity on each populations’ patient, visit, and medication acceptance characteristics. Reach to “current tobacco users” was analyzed using TTP flowsheet and electronic health record (EHR) data in relation to aggregate EHR data in the data warehouse. RESULTS: Mean monthly tobacco treatment inpatient counseling and outreach visits increased 38.9% in the telehealth period (M = 376, SD = 36.7) compared with the pre-telehealth period (M = 271, SD = 50.0) (t(10) = 3.8, p = .004). Reach significantly increased from 32.8% to 65.9% among all “current tobacco users” admitted, including 31.8% to 66.6% in races at higher risk for COVID-19 severe disease. Pearson’s chi-square tests for homogeneity showed significant differences in the pre-telehealth and telehealth population distributions for age, visit type, ethnicity, and medication acceptance. CONCLUSIONS: This study offers the first understanding of characteristics of patients, visits, and medication acceptances in pre-telehealth and telehealth tobacco use treatment for inpatient populations. Larger reach and counseling were identified in the telehealth population. This study’s findings on inpatient tobacco use treatment can inform future reach and engagement of large numbers of patients who use tobacco products. IMPLICATIONS: This study provides the first analysis of inpatient tobacco use treatment transition to telehealth delivery of care during the COVID-19 pandemic. The transition resulted in increases in reach and cessation counseling. These findings can inform efforts to improve reach, engagement, and research on telehealth delivery of inpatient tobacco use treatment. Oxford University Press 2021-12-21 /pmc/articles/PMC8962722/ /pubmed/34929731 http://dx.doi.org/10.1093/ntr/ntab233 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_modelThis article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
spellingShingle Brief Reports
Shoenbill, Kimberly A
Newcomer, Eiman
Valcourt-Hall, Celeslie
Baca-Atlas, Michael H
Smith, Caleb A
Goldstein, Adam O
An Analysis of Inpatient Tobacco Use Treatment Transition to Telehealth
title An Analysis of Inpatient Tobacco Use Treatment Transition to Telehealth
title_full An Analysis of Inpatient Tobacco Use Treatment Transition to Telehealth
title_fullStr An Analysis of Inpatient Tobacco Use Treatment Transition to Telehealth
title_full_unstemmed An Analysis of Inpatient Tobacco Use Treatment Transition to Telehealth
title_short An Analysis of Inpatient Tobacco Use Treatment Transition to Telehealth
title_sort analysis of inpatient tobacco use treatment transition to telehealth
topic Brief Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962722/
https://www.ncbi.nlm.nih.gov/pubmed/34929731
http://dx.doi.org/10.1093/ntr/ntab233
work_keys_str_mv AT shoenbillkimberlya ananalysisofinpatienttobaccousetreatmenttransitiontotelehealth
AT newcomereiman ananalysisofinpatienttobaccousetreatmenttransitiontotelehealth
AT valcourthallceleslie ananalysisofinpatienttobaccousetreatmenttransitiontotelehealth
AT bacaatlasmichaelh ananalysisofinpatienttobaccousetreatmenttransitiontotelehealth
AT smithcaleba ananalysisofinpatienttobaccousetreatmenttransitiontotelehealth
AT goldsteinadamo ananalysisofinpatienttobaccousetreatmenttransitiontotelehealth
AT shoenbillkimberlya analysisofinpatienttobaccousetreatmenttransitiontotelehealth
AT newcomereiman analysisofinpatienttobaccousetreatmenttransitiontotelehealth
AT valcourthallceleslie analysisofinpatienttobaccousetreatmenttransitiontotelehealth
AT bacaatlasmichaelh analysisofinpatienttobaccousetreatmenttransitiontotelehealth
AT smithcaleba analysisofinpatienttobaccousetreatmenttransitiontotelehealth
AT goldsteinadamo analysisofinpatienttobaccousetreatmenttransitiontotelehealth